CDK4 and cancer: Decreased expression of Ki-67 in DE-EDCP treated 4T1 cells could be the result of G0/G1 cell cycle arrest and increased expression of CDK4/CDK6 inhibitor, p16, as it was previously shown in normal and cancer cells [35].